🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,740
-400 (-3.29%)
Nov 20, 2026, 3:30 PM KST

Kolon TissueGene Market Cap

Kolon TissueGene has a market cap or net worth of 997.55 billion as of November 20, 2026. It is the 11,193rd most valuable company in the world and the 281st biggest in South Korea. Its market cap has decreased by 77.72% in one year.

Market Cap
997.55B
Enterprise Value
964.99B
Revenue
4.80B
Global Rank
Country Rank
#281 South Korea
PE Ratio
n/a

Chart

Chart

Since November 6, 2017, Kolon TissueGene's market cap has decreased from 2.58T to 997.55B, a decrease of -61.31%. That is a compound annual growth rate of -9.97%.

History

DateMarket Cap% Change
Nov 20, 2026997.55B-84.94%
Dec 30, 20256.62T258.54%
Dec 30, 20241.85T181.73%
Dec 28, 2023655.80B7.08%
Dec 29, 2022612.43B-76.74%
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Nov 6, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
Peptron2.01T
ABL Bio1.97T
LigaChem Biosciences1.92T
Voronoi1.91T
OliX Pharmaceuticals1.76T
D&D Pharmatech1.55T
Chabiotech676.19B
Proteina645.56B
Market Cap Rankings